JOURNAL 3321


Records of Natural Products
VOLUME & ISSUE
Available Online: January 04,2025
PAGES
p.1 - 6
DOI ADDRESS
http://doi.org/10.25135/rnp.491.2409.3321
(DOI number will be activated after the manuscript has been available in an issue.)
STATISTICS
Viewed 178 times.
AUTHORS
  • José L. Salvador-Hernández
  • Luis J. Calvillo-Carranza
  • Rosa E. del Río
  • Joel E. López-Meza
  • Alejandra Ochoa-Zarzosa
  • Julio C. Ontiveros-Rodríguez
  • Carlos M. Cerda-García-Rojas
  • Hugo A. García-Gutiérrez
PDF OF ARTICLE

GRAPHICAL ABSTRACT


ABSTRACT


The dichloromethane (DCM) and ethyl acetate (EtOAc) extracts of C. caeruleus yielded nine known compounds, including an A-nor-lupane triterpenoid identified as gouanic acid B (1). Additionally, its acetyl derivative, acetylgouanic acid B (2), is reported here for the first time as a natural product. Furthermore, we tested the bioactivity of natural products 1 and 2 and their dimethyl ester derivatives 3 and 4 against cancer cell lines MCF-7, A549, HeLa, and K562. Among these, compounds 1 (IC50 = 36.4 ± 4.0 μM), 2 (IC50 = 21.6 ± 4.3 μM), and 4 (IC50 = 33.0 ± 2.0 μM) demonstrated moderate to good activity against the K562 cell line while maintaining a satisfactory survival rate in non-cancerous bMEC cells. Notably, the natural triterpenes 1 and 2 and derivative 4 showed remarkable outcomes in cytotoxicity tests due to their specificity against K562 leukemia cells.

KEYWORDS
  • Ceanothus caeruleus
  • triterpenoid
  • bioactive compounds
  • cytotoxicity activity
  • non-cancerous cell line

SUPPORTING INFORMATION


Supporting Information Identification of the main specialized metabolites of Ceanothus caeruleus and cytotoxic effects of A-nor-lupane derivatives
Download File Templatesupporting-RNP JLSH Ceanothus.docx (6.02 MB)